ENTITY
Hugel Inc

Hugel Inc (145020 KS)

63
Analysis
Health Care • South Korea
Hugel, Inc. is a Bio-pharmaceutical company that focuses on developing beauty/cosmetics related products. The Company's main products include botulinum toxin and fillers.
more
bearish•Hugel Inc
•29 Jun 2020 18:11

Hugel Placement: A 5.2% Block Deal Sale

After the market close today, it was reported that BK Medical Group’s Chairman Dr. Kim Byung-Gun and Dr. BK Corp will sell their 5.2% stake...

Logo
477 Views
Share
•28 Mar 2019 07:36

Daewoong: Entering "Botox World"

Daewoong Pharmaceutical Co (069620 KS) has traded up over the past year in anticipation of the launch of its botulinum toxin product Jeuveau in the...

Share
bearish•Sejong Medical Co Ltd
•09 May 2018 11:46

Sejong Medical IPO Preview (Part 2) - Valuation Analysis

Sejong Medical Comparable Companies Valuation AnalysisWe are negative on the Sejong Medical IPO. The four major comps that the bankers used for...

Logo
321 Views
Share
bullish•Sejong Medical Co Ltd
•20 Apr 2018 23:00

Sejong Medical IPO Preview (Part 1)

Sejong Medical Co Ltd (258830 KS) is an IPO in Korea that is expected to be completed in May 2018. Sejong Medical is a medical device maker in...

Logo
388 Views
Share
•17 Jan 2018 15:06

KRX 300 - Selection Process Summary & Current Mood

Feb 5 is our big day. On Feb 5 the KRX will announce more details about this highly anticipated and much awaited new KOSPI+KOSDAQ integrated...

Logo
655 Views
Share
x